NEW YORK (

TheStreet

) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today.

Sign up for free email delivery of our daily Top 10.

Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon

Adam Feuerstein

Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers. (Stocks include GILD, CHTP, DNDN ONXX)

More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More

Adam Feuerstein

Biotech columnist Adam Feuerstein responds to biotech stock questions posed by his Twitter followers.

Sirius Moves Closer to Being Bought (Update 1)

Chris Ciaccia

Liberty Media may double its stake to 80%, some analysts say.

10 Stocks to Own During a Dividend Bubble (Update 1)

Frank Byrt

Investors are better off balancing dividends and share-price appreciation.

3 Stocks Investors Are Selling but Should Be Buying

Andrea Tse

A 'contrarian' approach can yield big returns if investors target quality stocks.

5 Best Performing Bank Stocks in 2012

Shanthi Bharatwaj

Hopes that the European crisis might not have a significant impact on the U.S. economy and expectations that there will be greater clarity on the regulatory front have helped turn the tide for bank stocks.

Stocks Reverse Course on Bernanke Testimony

Chao Deng

Less dovish comments from Fed chief Ben Bernanke steal the market's momentum from earlier positive reads on economic growth and business activity.

Bank of America, AIG Get Upgrades

Alexandra Zendrian

These stocks receive upgrades from TheStreet Ratings on Wednesday.

Analysts' Actions: AAPL, VPHM, CVX

TheStreet Staff

Here are today's top research calls.

5 Bank Stocks That Won't Bankrupt You or America (Update 1)

Philip van Doorn

Many of this year's best bank stock performers have still not recovered from their 2011 losses. These five quality names have lagged the financial sector so far this year, but performed well last year, highlighting the group's lower relative risk.

This article was written by a staff member of TheStreet.